These medications work by mimicking the GLP-1 hormone, which helps regulate blood sugar levels, slow digestion, and suppress appetite
For most users interested in a single-ingredient NAD+ booster, we would recommend NMN, thanks to its superior quantity and quality of supportive research, as well as the fact that NMN is metabolically one step closer to cellular NAD+ than NR is
V.GopalS.DeikA.et al
But many GLP-1 users do not need another program layer
Patients with a BMI of 30 kg/m or greater, or BMI of 27 kg/m with weight-related comorbidities (hypertension, type 2 diabetes, dyslipidemia), generally meet baseline medical criteria for GLP-1 therapy
Thus, timing also holds significance in optimizing effectiveness